ARTICLE | Company News
City of Hope, Novonco Therapeutics deal
August 24, 2015 7:00 AM UTC
City of Hope granted Novonco exclusive rights to COH29. The small molecule ribonucleotide reductase inhibitor is in preclinical testing to treat cancer. Novonco plans to start U.S. clinical trials t...